GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmagreen Biotech Inc (OTCPK:PHBI) » Definitions » Price-to-Tangible-Book

Pharmagreen Biotech (Pharmagreen Biotech) Price-to-Tangible-Book : (As of Jun. 06, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Pharmagreen Biotech Price-to-Tangible-Book?

As of today (2024-06-06), Pharmagreen Biotech's share price is $0.0009. Pharmagreen Biotech's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was $-0.01. Hence, Pharmagreen Biotech's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Pharmagreen Biotech's Price-to-Tangible-Book or its related term are showing as below:

PHBI's Price-to-Tangible-Book is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.28
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Pharmagreen Biotech's share price is $0.0009. Pharmagreen Biotech's Book Value per Sharefor the quarter that ended in Jun. 2023 was $-0.01. Hence, Pharmagreen Biotech's P/B Ratio of today is .


Pharmagreen Biotech Price-to-Tangible-Book Historical Data

The historical data trend for Pharmagreen Biotech's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagreen Biotech Price-to-Tangible-Book Chart

Pharmagreen Biotech Annual Data
Trend Apr08 Apr09 Sep18 Sep19 Sep20 Sep21 Sep22
Price-to-Tangible-Book
Get a 7-Day Free Trial - - - - -

Pharmagreen Biotech Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pharmagreen Biotech's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmagreen Biotech's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Pharmagreen Biotech's Price-to-Tangible-Book falls into.



Pharmagreen Biotech Price-to-Tangible-Book Calculation

Pharmagreen Biotech's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2023 )
=0.0009/-0.005
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Pharmagreen Biotech Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Pharmagreen Biotech's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmagreen Biotech (Pharmagreen Biotech) Business Description

Traded in Other Exchanges
N/A
Address
112 North Curry Street, Carson, NV, USA, 89703
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.

Pharmagreen Biotech (Pharmagreen Biotech) Headlines